Download full report with analyst certification and important disclosures
Oct 13 2026, 07:10 IST/BST
Givaudan delivered Q3 like-for-like (LFL) sales growth of 8.6%, which was well ahead of expectations. Fragrance & Beauty was the standout performer with exceptional growth in Fine Fragrance. Taste & Wellbeing improved sequentially despite US weakness. We expect momentum to continue into Q4 and see modest upside risk to consensus EBITDA forecasts for 2026.
Oct 13 2026, 07:10 IST/BST